The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nutritional Supplements in Psychiatric Disorders Market Research Report 2025

Global Nutritional Supplements in Psychiatric Disorders Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903354

No of Pages : 102

Synopsis
Nutritional supplements in psychiatric disorders refer to the use of vitamins, minerals, fatty acids, amino acids, and other nutrients to support and improve mental health and address specific psychiatric conditions. The rationale behind using these supplements is that certain nutritional deficiencies or imbalances may contribute to the symptoms of psychiatric disorders, or that additional supplementation may have a therapeutic effect.
The global Nutritional Supplements in Psychiatric Disorders market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nutritional Supplements in Psychiatric Disorders is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nutritional Supplements in Psychiatric Disorders is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nutritional Supplements in Psychiatric Disorders include Now Foods, Nature’s Bounty, Garden of Life, Nordic Naturals, Jarrow Formulas, Thorne Research, Pure Encapsulations, Integrative Therapeutics and Life Extension, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nutritional Supplements in Psychiatric Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nutritional Supplements in Psychiatric Disorders.
Report Scope
The Nutritional Supplements in Psychiatric Disorders market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nutritional Supplements in Psychiatric Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nutritional Supplements in Psychiatric Disorders manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Now Foods
Nature’s Bounty
Garden of Life
Nordic Naturals
Jarrow Formulas
Thorne Research
Pure Encapsulations
Integrative Therapeutics
Life Extension
Metagenics
Segment by Type
Omega-3 Fatty Acids
Amino Acids
Vitamins
Herbal Supplements
Others
Segment by Application
Clinical Practice
Research and Development
Personalized Medicine
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nutritional Supplements in Psychiatric Disorders manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Nutritional Supplements in Psychiatric Disorders by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Nutritional Supplements in Psychiatric Disorders in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index
1 Nutritional Supplements in Psychiatric Disorders Market Overview
1.1 Product Definition
1.2 Nutritional Supplements in Psychiatric Disorders Segment by Type
1.2.1 Global Nutritional Supplements in Psychiatric Disorders Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Omega-3 Fatty Acids
1.2.3 Amino Acids
1.2.4 Vitamins
1.2.5 Herbal Supplements
1.2.6 Others
1.3 Nutritional Supplements in Psychiatric Disorders Segment by Application
1.3.1 Global Nutritional Supplements in Psychiatric Disorders Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Clinical Practice
1.3.3 Research and Development
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Nutritional Supplements in Psychiatric Disorders Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Nutritional Supplements in Psychiatric Disorders Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Nutritional Supplements in Psychiatric Disorders Production Estimates and Forecasts (2019-2030)
1.4.4 Global Nutritional Supplements in Psychiatric Disorders Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nutritional Supplements in Psychiatric Disorders Production Market Share by Manufacturers (2019-2024)
2.2 Global Nutritional Supplements in Psychiatric Disorders Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Nutritional Supplements in Psychiatric Disorders, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Nutritional Supplements in Psychiatric Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Nutritional Supplements in Psychiatric Disorders Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Nutritional Supplements in Psychiatric Disorders, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nutritional Supplements in Psychiatric Disorders, Product Offered and Application
2.8 Global Key Manufacturers of Nutritional Supplements in Psychiatric Disorders, Date of Enter into This Industry
2.9 Nutritional Supplements in Psychiatric Disorders Market Competitive Situation and Trends
2.9.1 Nutritional Supplements in Psychiatric Disorders Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nutritional Supplements in Psychiatric Disorders Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nutritional Supplements in Psychiatric Disorders Production by Region
3.1 Global Nutritional Supplements in Psychiatric Disorders Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Nutritional Supplements in Psychiatric Disorders Production Value by Region (2019-2030)
3.2.1 Global Nutritional Supplements in Psychiatric Disorders Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Nutritional Supplements in Psychiatric Disorders by Region (2025-2030)
3.3 Global Nutritional Supplements in Psychiatric Disorders Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Nutritional Supplements in Psychiatric Disorders Production by Region (2019-2030)
3.4.1 Global Nutritional Supplements in Psychiatric Disorders Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Nutritional Supplements in Psychiatric Disorders by Region (2025-2030)
3.5 Global Nutritional Supplements in Psychiatric Disorders Market Price Analysis by Region (2019-2024)
3.6 Global Nutritional Supplements in Psychiatric Disorders Production and Value, Year-over-Year Growth
3.6.1 North America Nutritional Supplements in Psychiatric Disorders Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Nutritional Supplements in Psychiatric Disorders Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Nutritional Supplements in Psychiatric Disorders Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Nutritional Supplements in Psychiatric Disorders Production Value Estimates and Forecasts (2019-2030)
4 Nutritional Supplements in Psychiatric Disorders Consumption by Region
4.1 Global Nutritional Supplements in Psychiatric Disorders Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Nutritional Supplements in Psychiatric Disorders Consumption by Region (2019-2030)
4.2.1 Global Nutritional Supplements in Psychiatric Disorders Consumption by Region (2019-2024)
4.2.2 Global Nutritional Supplements in Psychiatric Disorders Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Nutritional Supplements in Psychiatric Disorders Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Nutritional Supplements in Psychiatric Disorders Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nutritional Supplements in Psychiatric Disorders Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Nutritional Supplements in Psychiatric Disorders Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Nutritional Supplements in Psychiatric Disorders Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Nutritional Supplements in Psychiatric Disorders Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nutritional Supplements in Psychiatric Disorders Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Nutritional Supplements in Psychiatric Disorders Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Nutritional Supplements in Psychiatric Disorders Production by Type (2019-2030)
5.1.1 Global Nutritional Supplements in Psychiatric Disorders Production by Type (2019-2024)
5.1.2 Global Nutritional Supplements in Psychiatric Disorders Production by Type (2025-2030)
5.1.3 Global Nutritional Supplements in Psychiatric Disorders Production Market Share by Type (2019-2030)
5.2 Global Nutritional Supplements in Psychiatric Disorders Production Value by Type (2019-2030)
5.2.1 Global Nutritional Supplements in Psychiatric Disorders Production Value by Type (2019-2024)
5.2.2 Global Nutritional Supplements in Psychiatric Disorders Production Value by Type (2025-2030)
5.2.3 Global Nutritional Supplements in Psychiatric Disorders Production Value Market Share by Type (2019-2030)
5.3 Global Nutritional Supplements in Psychiatric Disorders Price by Type (2019-2030)
6 Segment by Application
6.1 Global Nutritional Supplements in Psychiatric Disorders Production by Application (2019-2030)
6.1.1 Global Nutritional Supplements in Psychiatric Disorders Production by Application (2019-2024)
6.1.2 Global Nutritional Supplements in Psychiatric Disorders Production by Application (2025-2030)
6.1.3 Global Nutritional Supplements in Psychiatric Disorders Production Market Share by Application (2019-2030)
6.2 Global Nutritional Supplements in Psychiatric Disorders Production Value by Application (2019-2030)
6.2.1 Global Nutritional Supplements in Psychiatric Disorders Production Value by Application (2019-2024)
6.2.2 Global Nutritional Supplements in Psychiatric Disorders Production Value by Application (2025-2030)
6.2.3 Global Nutritional Supplements in Psychiatric Disorders Production Value Market Share by Application (2019-2030)
6.3 Global Nutritional Supplements in Psychiatric Disorders Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Now Foods
7.1.1 Now Foods Nutritional Supplements in Psychiatric Disorders Corporation Information
7.1.2 Now Foods Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.1.3 Now Foods Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Now Foods Main Business and Markets Served
7.1.5 Now Foods Recent Developments/Updates
7.2 Nature’s Bounty
7.2.1 Nature’s Bounty Nutritional Supplements in Psychiatric Disorders Corporation Information
7.2.2 Nature’s Bounty Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.2.3 Nature’s Bounty Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Nature’s Bounty Main Business and Markets Served
7.2.5 Nature’s Bounty Recent Developments/Updates
7.3 Garden of Life
7.3.1 Garden of Life Nutritional Supplements in Psychiatric Disorders Corporation Information
7.3.2 Garden of Life Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.3.3 Garden of Life Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Garden of Life Main Business and Markets Served
7.3.5 Garden of Life Recent Developments/Updates
7.4 Nordic Naturals
7.4.1 Nordic Naturals Nutritional Supplements in Psychiatric Disorders Corporation Information
7.4.2 Nordic Naturals Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.4.3 Nordic Naturals Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Nordic Naturals Main Business and Markets Served
7.4.5 Nordic Naturals Recent Developments/Updates
7.5 Jarrow Formulas
7.5.1 Jarrow Formulas Nutritional Supplements in Psychiatric Disorders Corporation Information
7.5.2 Jarrow Formulas Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.5.3 Jarrow Formulas Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Jarrow Formulas Main Business and Markets Served
7.5.5 Jarrow Formulas Recent Developments/Updates
7.6 Thorne Research
7.6.1 Thorne Research Nutritional Supplements in Psychiatric Disorders Corporation Information
7.6.2 Thorne Research Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.6.3 Thorne Research Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Thorne Research Main Business and Markets Served
7.6.5 Thorne Research Recent Developments/Updates
7.7 Pure Encapsulations
7.7.1 Pure Encapsulations Nutritional Supplements in Psychiatric Disorders Corporation Information
7.7.2 Pure Encapsulations Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.7.3 Pure Encapsulations Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Pure Encapsulations Main Business and Markets Served
7.7.5 Pure Encapsulations Recent Developments/Updates
7.8 Integrative Therapeutics
7.8.1 Integrative Therapeutics Nutritional Supplements in Psychiatric Disorders Corporation Information
7.8.2 Integrative Therapeutics Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.8.3 Integrative Therapeutics Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Integrative Therapeutics Main Business and Markets Served
7.7.5 Integrative Therapeutics Recent Developments/Updates
7.9 Life Extension
7.9.1 Life Extension Nutritional Supplements in Psychiatric Disorders Corporation Information
7.9.2 Life Extension Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.9.3 Life Extension Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Life Extension Main Business and Markets Served
7.9.5 Life Extension Recent Developments/Updates
7.10 Metagenics
7.10.1 Metagenics Nutritional Supplements in Psychiatric Disorders Corporation Information
7.10.2 Metagenics Nutritional Supplements in Psychiatric Disorders Product Portfolio
7.10.3 Metagenics Nutritional Supplements in Psychiatric Disorders Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Metagenics Main Business and Markets Served
7.10.5 Metagenics Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nutritional Supplements in Psychiatric Disorders Industry Chain Analysis
8.2 Nutritional Supplements in Psychiatric Disorders Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nutritional Supplements in Psychiatric Disorders Production Mode & Process
8.4 Nutritional Supplements in Psychiatric Disorders Sales and Marketing
8.4.1 Nutritional Supplements in Psychiatric Disorders Sales Channels
8.4.2 Nutritional Supplements in Psychiatric Disorders Distributors
8.5 Nutritional Supplements in Psychiatric Disorders Customers
9 Nutritional Supplements in Psychiatric Disorders Market Dynamics
9.1 Nutritional Supplements in Psychiatric Disorders Industry Trends
9.2 Nutritional Supplements in Psychiatric Disorders Market Drivers
9.3 Nutritional Supplements in Psychiatric Disorders Market Challenges
9.4 Nutritional Supplements in Psychiatric Disorders Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’